版本:
中国

BRIEF-Oncodesign says option to license rights for Parkinson Program from Ipsen

March 15 Oncodesign Sa

* Oncodesign announces return of research collaboration and option to license rights for parkinson program from Ipsen

* Oncodesign recovers full rights to LRRK2 program and patent portfolio

* Following reacquisition, Oncodesign now intends to pursue further development of LRRK2 based parkinson program internally Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐